NovaBay Pharmaceuticals, Inc. EBIT Margin

EBIT Margin of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBIT Margin growth rates and interactive chart. Earnings before interest and taxes margin is an indicator of a company's profitability. Calculated as earnings before interest and taxes (EBIT) divided by revenue. It is useful for comparison of companies with different debt levels and tax rates. And EBIT margin gives a clear picture about the underlying profitability of a company's core operations. EBIT is also referred to as operating earnings, operating profit, and profit before interest and taxes.


Highlights and Quick Summary

  • EBIT Margin for the quarter ending June 30, 2022 was -70.67% (a -22.0% decrease compared to previous quarter)
  • Year-over-year quarterly EBIT Margin decreased by -43.19%
  • Annual EBIT Margin for 2021 was -105.24% (a 62.68% increase from previous year)
  • Annual EBIT Margin for 2020 was -64.69% (a -54.59% decrease from previous year)
  • Annual EBIT Margin for 2019 was -142.45% (a 126.36% increase from previous year)
  • Twelve month EBIT Margin ending June 30, 2022 was -98.64% (a -6.24% decrease compared to previous quarter)
  • Twelve month trailing EBIT Margin increased by 1.86% year-over-year
Trailing EBIT Margin for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-98.64% -105.2% -105.24% -96.84%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBIT Margin of NovaBay Pharmaceuticals, Inc.

Most recent EBIT Marginof NBY including historical data for past 10 years.

Interactive Chart of EBIT Margin of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. EBIT Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -70.67% -90.6%
2021 -120.94% -124.4% -87.15% -84.12% -105.24%
2020 -93.11% -95.02% -26.88% -81.13% -64.69%
2019 -131.34% -106.01% -77.08% -273.04% -142.45%
2018 -44.44% -57.57% -74.55% -80.35% -62.93%
2017 6.21% -53.02% -42.62% -102.05% -40.1%
2016 -49.79% -59.95% -84.12% -270.56% -92.31%
2015 -383.43% -445.67% -482.04% -866.36% -482.47%
2014 -999.39% -2705.92% -3078.05% -1422.92% -1603.8%
2013 -954.31% -271.34% -489.39% -341.86% -445.38%
2012 -255.21% -2.91% -330.08% -188.26% -119.61%
2011 -200.65% -12.55% -39.21%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology